On Wednesday, Shares of JPMorgan Chase & Co. (NYSE:JPM), gained 1.82% to $62.57.
JPMorgan Chase & Co., will host a conference call to review fourth quarter 2015 financial results on Thursday, January 14, 2016 at 8:30 a.m. (Eastern). The results are planned to be released at 7:00 a.m. (Eastern).
JPMorgan Chase & Co. provides various financial services worldwide. The company operates through four segments: Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset Administration.
Shares of Abbott Laboratories (NYSE:ABT), inclined 1.54% to $44.24, during its last trading session.
Abbott Laboratories declared that it has accomplished its acquisition of Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies. Abbott attained the equity of Tendyne that it did not already own for $225 million upfront, resulting in a total transaction value of $250 million, plus potential future payments tied to regulatory milestones.
Tendyne’s Bioprosthetic Mitral Valve System is designed to be implanted in a beating heart, without the need for open heart surgery, which would be a new treatment option for mitral valve replacement. It is an investigational device and not presently available for sale. The U.S. Food and Drug Administration has given approval for a feasibility clinical trial to provide data about the device’s safety and effectiveness. The trial has begun enrolling patients, and there are plans to start enrollment next year in a clinical trial to support CE Mark in Europe.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms.
Finally, Stratasys Ltd. (NASDAQ:SSYS), ended its last trade with 1.90% gain, and closed at $29.45.
Stratasys Ltd. is now accepting entries for the 12th annual Extreme Redesign 3D Printing Challenge.
Open to students worldwide, this annual 3D printing challenge invites students in engineering, design and art or architecture to design a new product that improves how a task is accomplished or to redesign an existing product. Entries should be mechanically sound, realistic and achievable, and are judged based on:
- Sound mechanical design
- Compelling description (written and/or video)
- Design creativity
- Product usefulness
- Aesthetics (art and architecture category)
Individual students or two-person teams are required to create designs using 3D CAD software and to submit their files in .STL format to Stratasys online, together with a written description and/or a 30-second video explaining the value and benefit of the Extreme Redesign model. The deadline to submit entries is Feb. 4, 2016. Categories comprise:
- Engineering: Secondary Education (middle and high school)
- Engineering: Post-Secondary (university, college or post-secondary)
- Art or architecture (any grade level)
Stratasys Ltd. provides additive manufacturing (AM) solutions for the creation of parts used in the processes of designing and manufacturing products; and for the direct manufacture of end parts.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
